<p>This study uses normal and tumor tissues from breast cancer patients to derive 3D cell culture models called organoids. Organoid technology is an innovative platform that can be used to study a patient's tumor in a dish <i>ex-vivo</i>. As part of this study we have comprehensively characterized these models using next-generation sequencing for: 1) pathogenic SNVs in a targeted gene panel 2) copy number alterations 3) transcriptome analysis using RNA sequencing and 4) single-cell RNA sequencing</p>

Patient-Derived Breast Cancer Organoid Study

Neoplasms study with OTHER, RNA-Seq + 2 more data on dbGaP (95 participants)

Patient-Derived Breast Cancer Organoid Study

Description

Applying For Access

Summary